CAS RN: 342613-63-2
methyl 3-bromoH-imidazo[1,2-a]pyridine-7-carboxylate
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250216 |
1g / 5g |
Confirm by inquiry |
Shanghai | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.25g, 1g, 5g, 10g, 25g
- Available purity: >95%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 342613-63-2
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.25g |
>95% |
1
In Stock
|
Hong Kong |
Inquiry |
| 1g |
>95% |
1
In Stock
|
Hong Kong |
Inquiry |
| 5g |
>95% |
1
In Stock
|
Beijing |
Inquiry |
| 10g |
>95% |
1
In Stock
|
Beijing |
Inquiry |
| 25g |
>95% |
0
Out of Stock
|
Shenzhen |
Inquiry |
342613-63-2 / methyl 3-bromoimidazo[1,2-a]pyridine-7-carboxylate
Standard CAS: 342613-63-2
Multi CAS: No
Basic Information
CAS
342613-63-2
Multi CAS
No
Molecular Formula
BC9H7O2Rn2
Molecular Weight
255.070000
Exact Mass
253.969090
InChI
InChI=1S/C9H7BrN2O2/c1-14-9(13)6-2-3-12-7(10)5-11-8(12)4-6/h2-5H,1H3
InChIKey
VFFFBWRUZMAHFS-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
14
Aromatic heavy atom count
9
Fraction Csp3
0.11
Rotatable bonds
1
H-bond acceptors
4
Molar refractivity
54.23
TPSA
43.6
LogP / Solubility
WLOGP
1.88
MLOGP
1.66
XLogP3
2.6
Consensus LogP
2.05
Log S (ESOL)
-3.02
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.01
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.94
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
1.5